User menu

Impact of ribotype 027 on Clostridium difficile infection in a geriatric department.

Bibliographic reference Mascart, G ; Delmée, Michel ; Van Broeck, Johan ; Cytryn, E ; Karmali, R ; et. al. Impact of ribotype 027 on Clostridium difficile infection in a geriatric department.. In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Vol. 32, no. 9, p. 1177-82 (2013)
Permanent URL http://hdl.handle.net/2078.1/133597
  1. Simor Andrew E., Bradley Suzanne F., Strausbaugh Larry J., Crossley Kent, Nicolle Lindsay E., , Clostridium difficile in Long-Term–Care Facilities for the Elderly, 10.1086/501997
  2. Cherifi S., Delmee M., Broeck J. Van, Beyer I., Byl B., Mascart G., Management of an Outbreak of Clostridium difficile–Associated Disease Among Geriatric Patients, 10.1086/507822
  3. Charlson Mary E., Pompei Peter, Ales Kathy L., MacKenzie C.Ronald, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, 10.1016/0021-9681(87)90171-8
  4. Cohen Stuart H., Gerding Dale N., Johnson Stuart, Kelly Ciaran P., Loo Vivian G., McDonald L. Clifford, Pepin Jacques, Wilcox Mark H., Clinical Practice Guidelines forClostridium difficileInfection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), 10.1086/651706
  5. Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38(7):2484–2487
  6. Loo Vivian G., Poirier Louise, Miller Mark A., Oughton Matthew, Libman Michael D., Michaud Sophie, Bourgault Anne-Marie, Nguyen Tuyen, Frenette Charles, Kelly Mirabelle, Vibien Anne, Brassard Paul, Fenn Susan, Dewar Ken, Hudson Thomas J., Horn Ruth, René Pierre, Monczak Yury, Dascal André, A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality, 10.1056/nejmoa051639
  7. Ricciardi Rocco, Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States, 10.1001/archsurg.142.7.624
  8. Weiss Karl, Bergeron Luc, Bernatchez Harold, Goyette Monique, Savoie Michel, Thirion Daniel, Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004, 10.1016/j.ijantimicag.2007.05.020
  9. Viseur N, Lambert M-L (2012) Epidémiologie des infections à Clostridium difficile en Belgique. Rapport 2012. Available online at: https://www.wiv-isp.be/nsih/download/CDIF/CDIF-AR-2012-FR.pdf
  10. Kuijper E.J., Coignard B., Tüll P., Emergence of Clostridium difficile-associated disease in North America and Europe, 10.1111/j.1469-0691.2006.01580.x
  11. Pepin J., Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity, 10.1503/cmaj.1041104
  12. Joseph R, Demeyer D, Vanrenterghem D, van den Berg R, Kuijper E, Delmée M (2005) First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill 10(10):E051020.4
  13. Tachon M, Cattoen C, Blanckaert K, Poujol I, Carbonne A, Barbut F, Petit JC, Coignard B (2006) First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 11(5):E060504.1
  14. Warny Michel, Pepin Jacques, Fang Aiqi, Killgore George, Thompson Angela, Brazier Jon, Frost Eric, McDonald L Clifford, Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe, 10.1016/s0140-6736(05)67420-x
  15. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Åkerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13(31). pii: 18942. http://www.eurosurveillance.org/ViewArticle.aspx?Articleid=18942
  16. Costers M, Viseur N, Catry B, Simon A (2012) Four multifaceted countrywide campaigns to promote hand hygiene in Belgian hospitals between 2005 and 2011: impact on compliance to hand hygiene. Euro Surveill 17(18). pii: 20161. http://www.eurosurveillance.org/ViewArticle.aspx?Articleid=20161
  17. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A., New trends in Clostridium difficile virulence and pathogenesis, 10.1016/s0924-8579(09)70012-3
  18. McDonald L. Clifford, Killgore George E., Thompson Angela, Owens Robert C., Kazakova Sophia V., Sambol Susan P., Johnson Stuart, Gerding Dale N., An Epidemic, Toxin Gene–Variant Strain ofClostridium difficile, 10.1056/nejmoa051590
  19. Bruns A. H. W., Oosterheert J. J., Kuijper E. J., Lammers J. W. J., Thijsen S., Troelstra A., Hoepelman A. I. M., Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile, 10.1093/jac/dkq329
  20. Gutiérrez I, Lambert ML (2010) Trends in mortality and morbidity related to Clostridium difficile infections, Belgium 1998–2007. Available online at: http://www.nsih.be/download/CDIF/CDI_trends_mortality_morbidity_final_report_June_2010.pdf
  21. Pepin J., Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec, 10.1503/cmaj.050978
  22. Simor Andrew E., Diagnosis, Management, and Prevention of Clostridium difficile Infection in Long-Term Care Facilities: A Review : CLOSTRIDIUM DIFFICILEINFECTION, 10.1111/j.1532-5415.2010.02958.x
  23. Hubert B., Loo V. G., Bourgault A.-M., Poirier L., Dascal A., Fortin E., Dionne M., Lorange M., A Portrait of the Geographic Dissemination of the Clostridium difficile North American Pulsed-Field Type 1 Strain and the Epidemiology of C. difficile-Associated Disease in Quebec, 10.1086/510391
  24. Zar F. A., Bakkanagari S. R., Moorthi K. M. L. S. T., Davis M. B., A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity, 10.1086/519265
  25. Pepin J., Alary M.-E., Valiquette L., Raiche E., Ruel J., Fulop K., Godin D., Bourassa C., Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada, 10.1086/430315
  26. Miendje Deyi VY, Vandenberg O, Mascart G, Gning S, Retore P, Douat N, Dediste A (2008) Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease. Clin Lab 54(1–2):9–13